160 related articles for article (PubMed ID: 1699592)
1. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
2. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
Smith ME; Marsh SG; Bodmer JG; Gelsthorpe K; Bodmer WF
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5557-61. PubMed ID: 2473473
[TBL] [Abstract][Full Text] [Related]
3. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
5. Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence.
Möller P; Koretz K; Schlag P; Momburg F
Int J Cancer Suppl; 1991; 6():155-62. PubMed ID: 1712347
[TBL] [Abstract][Full Text] [Related]
6. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
7. Defective expression of adhesion molecules on human bladder tumour and human tumour cell lines.
Nouri AM; Hussain RF; Dos Santos AV; Oliver RT
Urol Int; 1996; 56(1):6-12. PubMed ID: 8903546
[TBL] [Abstract][Full Text] [Related]
8. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
9. HLA-A, B and DR in Caucasians with transitional cell carcinoma of the bladder.
Saunders PH; Anderson SA; Stogdill VD; Lamm DL
Tissue Antigens; 1983 Nov; 22(5):389-92. PubMed ID: 6581580
[TBL] [Abstract][Full Text] [Related]
10. Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma.
Tomita Y; Matsumoto Y; Nishiyama T; Fujiwara M
J Pathol; 1990 Oct; 162(2):157-64. PubMed ID: 2250194
[TBL] [Abstract][Full Text] [Related]
11. Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer.
Kaklamanis L; Gatter KC; Hill AB; Mortensen N; Harris AL; Krausa P; McMichael A; Bodmer JG; Bodmer WF
Int J Cancer; 1992 May; 51(3):379-85. PubMed ID: 1592528
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines.
Ottesen SS; Ahrenkiel V; Kieler J
Cancer Immunol Immunother; 1990; 31(2):93-8. PubMed ID: 2108803
[TBL] [Abstract][Full Text] [Related]
13. Types of HLA in the bladder transitional cell carcinoma (TCC).
Yılmaz E; Uğur Özalp A; Cekmen A; Eren B; Onal B; Akkuş E; Erdoğan E
Med Glas (Zenica); 2013 Feb; 10(1):133-6. PubMed ID: 23348175
[TBL] [Abstract][Full Text] [Related]
14. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
[TBL] [Abstract][Full Text] [Related]
15. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma.
Gan LH; Huang LF; Zhang X; Lin A; Xu DP; Wang Q; Wang TJ; Yan WH
Hum Immunol; 2010 Sep; 71(9):899-904. PubMed ID: 20600448
[TBL] [Abstract][Full Text] [Related]
17. Histocompatibility profile of selected Latin American countries.
Santiago-Delpín EA
Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
[No Abstract] [Full Text] [Related]
18. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
[TBL] [Abstract][Full Text] [Related]
19. Cellular localization of blood group antigens (including HLA markers) in human bladder urothelium.
Gane P; Ruttyn Y; Rouger P; Vallancien G; Salmon C
Tissue Antigens; 1988 Aug; 32(2):57-70. PubMed ID: 3057680
[TBL] [Abstract][Full Text] [Related]
20. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma.
Momburg F; Ziegler A; Harpprecht J; Möller P; Moldenhauer G; Hämmerling GJ
J Immunol; 1989 Jan; 142(1):352-8. PubMed ID: 2462591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]